Exane Derivatives’s National Health Investors NHI Stock Holding History

Exane Derivatives’s Portfolio NHI Stock Details NHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$424	Hold	7	–	–	﹤0.01%	591
2022 Q1	$413	Hold	7	–	–	﹤0.01%	890
2021 Q4	$402	Hold	7	–	–	﹤0.01%	793
2021 Q3	$374	Hold	7	–	–	﹤0.01%	972
2021 Q2	$467	Hold	7	–	–	﹤0.01%	948
2021 Q1	$506	Hold	7	–	–	﹤0.01%	796
2020 Q4	$484	Sell	7 -132	-95%	-$8.39K	﹤0.01%	742
2020 Q3	$8.38K	Hold	139	–	–	﹤0.01%	476
2020 Q2	$8.44K	Sell	139 -2,161	-94%	-$119K	﹤0.01%	424
2020 Q1	$114K	Buy	+2,300	New	+$175K	0.03%	270
2018 Q3	–	Sell	-2	Closed	-$148	–	720
2018 Q2	$148	Sell	2 -4,316	-100%	-$305K	﹤0.01%	595
2018 Q1	$292K	Sell	4,318 -1,308	-23%	-$89.4K	0.06%	203
2017 Q4	$424K	Sell	5,626 -2,700	-32%	-$210K	0.07%	188
2017 Q3	$643K	Sell	8,326 -262	-3%	-$20.5K	0.12%	119
2017 Q2	$680K	Buy	8,588 +8,581	+122,586%	+$649K	0.15%	110
2017 Q1	$508	Hold	7	–	–	﹤0.01%	429
2016 Q4	$519	Sell	7 -9,748	-100%	-$716K	﹤0.01%	487
2016 Q3	$766K	Buy	+9,755	New	+$767K	0.11%	118

Other funds holding NHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LIMS

Lasalle Investment Management Securities Baltimore, Maryland $2.81B AUM 16.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Exane Derivatives's NHI Position: Q2 2022 in Review

Exane Derivatives held its National Health Investors (NHI) position steady in Q2 2022 at 7 shares worth $424. The position accounts for ﹤0.01% of the portfolio, ranked #591.

Exane Derivatives first reported a position in NHI in Q3 2016 and has held it in 18 quarters since. The position peaked at $766K in Q3 2016. 235 funds tracked by Wall St. Rank hold NHI as of Q2 2022.

Exane Derivatives held 7 shares of National Health Investors worth $424 as of Q2 2022.
Exane Derivatives left its National Health Investors share count unchanged in Q2 2022.
National Health Investors made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #591 holding.
Exane Derivatives first reported a position in National Health Investors in Q3 2016 and has held it in 18 quarters since.
Exane Derivatives's National Health Investors position peaked at $766K in Q3 2016.
235 funds tracked by Wall St. Rank held National Health Investors as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.